GAS5

ncRNA information

ncRNA name

GAS5

Specific or universal ncRNAs

Universal ncRNAs

Class

Long noncoding RNA

Biomarker

No

Biomarker application

Upstream regulatory factors

Not available

Downstream target

miR-221/SOCS3

Cancer information

Cancer name

Pancreatic Cancer

Cancer site

Pancreas

Treatment information

Treatment type

Chemotherapy

Drug

Gemcitabine

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Down

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Down

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

The results show that overexpression of GAS5 suppressed the proliferation, migration, gemcitabine resistance, stem celllike properties, and epithelial-mesenchymal transition (EMT) of PC cells by directly binding to and suppressing miR-221 expression and enhancing suppressor of cytokine signaling 3 (SOCS3) expression.

Tissue resource

carcinomas and adjacent tissue

human pancreatic cancer cell lines PANC-1

human pancreatic cancer cell lines AsPC-1

human pancreatic cancer cell lines Capan-2

human pancreatic cancer cell lines SW1990

human pancreatic cancer cell lines BXPC-3

human pancreatic ductal epithelial cell lines HPDE6-C7

Experiment

qRT-PCR,Western blot,Luciferase reporter assay


Institute

Tongren Hospital of Shanghai Jiaotong University School of Medicine

the laboratory of biliary-pancreatic surgery at Tongren Hospital

American Type Culture Collection

Country

China

USA

Continent

Asia

North American